Logo
x

Search

Subscribe Now

Acquired

Palatin Technologies' Vyleesi (bremelanotide injection) Receives FDA's Approval for Premenopausal Women with Acquired- Generalized Hypoactive Sexual Desire Disorder

Palatin Technologies' Vyleesi (bremelanotide injection) Receives FDA's Approval for Premenopausal Women with Acquired- Generalized...

  • June 22, 2019
Secura Bio Acquires WW Commercialization Rights to Novartis' Farydak for R/R Multiple Myeloma

Secura Bio Acquires WW Commercialization Rights to Novartis' Farydak for R/R Multiple Myeloma

  • March 13, 2019
Sanofi's Cablivi (caplacizumab-yhdp) Receives FDA's Approval for Acquired Thrombotic Thrombocytopenic Purpura (aTTP) in Adults

Sanofi's Cablivi (caplacizumab-yhdp) Receives FDA's Approval for Acquired Thrombotic Thrombocytopenic Purpura (aTTP) in Adults

  • February 7, 2019
Novartis to Acquire Endocyte for Expansion of its Investigational Radioligand Therapy (RLT) Platform

Novartis to Acquire Endocyte for Expansion of its Investigational Radioligand Therapy (RLT) Platform

  • October 18, 2018
Roche Acquires Tusk Therapeutics for $81. 24 M (€70M) for Its Novel Antibody

Roche Acquires Tusk Therapeutics for $81. 24 M (€70M) for Its Novel Antibody

  • October 1, 2018
Mylan quietly acquired undisclosed WW rights of a product for $463mn in July'18

Mylan quietly acquired undisclosed WW rights of a product for $463mn in July'18

  • August 16, 2018
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.